Zevra Therapeutics
(NASDAQ) ZVRA
Zevra Therapeutics Financials at a Glance
Market Cap
$515.49M
Revenue (TTM)
$106.47M
Net Income (TTM)
$83.23M
EPS (TTM)
$1.49
P/E Ratio
5.88
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Price
$9.11
Volume
2,316
Open
$8.88
Price
$9.11
Volume
2,316
Open
$8.88
Previous Close
$8.78
Daily Range
$8.88 - $9.17
52-Week Range
$6.19 - $13.16
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Price
$9.11
Volume
2,316
Open
$8.88
Previous Close
$8.78
Daily Range
$8.88 - $9.17
52-Week Range
$6.19 - $13.16
ZVRA News
ZVRA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Zevra Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
61
CEO
Neil F. McFarlane
Website
zevra.comHeadquarters
Celebration, FL 34747, US
ZVRA Financials
Key Financial Metrics (TTM)
Gross Margin
84%
Operating Margin
-59%
Net Income Margin
78%
Return on Equity
85%
Return on Capital
-26%
Return on Assets
29%
Earnings Yield
17.01%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$515.49M
Shares Outstanding
58.71M
Volume
2.32K
Short Interest
0.00%
Avg. Volume
1.11M
Financials (TTM)
Gross Profit
$89.99M
Operating Income
$4.23M
EBITDA
$98.71M
Operating Cash Flow
$1.60M
Capital Expenditure
$835.00K
Free Cash Flow
$2.43M
Cash & ST Invst.
$191.01M
Total Debt
$63.21M
Zevra Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$34.13M
+183.4%
Gross Profit
$32.60M
+205.4%
Gross Margin
95.55%
N/A
Market Cap
$515.49M
N/A
Market Cap/Employee
$8.74M
N/A
Employees
59
N/A
Net Income
$12.16M
+134.0%
EBITDA
$14.98M
+190.6%
Quarterly Fundamentals
Net Cash
$127.81M
+1289.2%
Accounts Receivable
$23.26M
+121.3%
Inventory
$1.74M
-11.7%
Long Term Debt
$62.79M
+4.9%
Short Term Debt
$419.00K
-0.2%
Return on Assets
29.23%
N/A
Return on Invested Capital
-25.64%
N/A
Free Cash Flow
$5.55M
+134.1%
Operating Cash Flow
$5.52M
+133.9%